We partner with international pharmaceutical companies to act as Swiss marketing authorization holder (MAH) and commercialize innovative medicines onto the Swiss market. Our teams are highly experienced and provide indepth expertise of commercial operations in domains like oncology and rare diseases
- http://www.sfl-pharma.ch
- +41 61 544 47 20
- info@sfl-pharma.ch
- Shayesteh Fürst-Ladani